18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas-Reference-Cited by-同舟云学术

18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas

Published:2015-04-09 Issue:10 Volume:25 Page:3009-3016
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Noda Yoshifumi,Kanematsu Masayuki,Goshima Satoshi,Suzui Natsuko,Hirose Yoshinobu,Matsunaga Kengo,Nishibori Hironori,Kondo Hiroshi,Watanabe Haruo,Kawada Hiroshi,Kawai Nobuyuki,Tanahashi Yukichi,Bae Kyongtae T.

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00330-015-3687-2.pdf

Reference45 articles.

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29

2. Leibovich BC, Lohse CM, Crispen PL et al (2010) Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol 183:1309–1315

3. Teloken PE, Thompson RH, Tickoo SK et al (2009) Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma. J Urol 182:2132–2136

4. Luciani LG, Cestari R, Tallarigo C (2000) Incidental renal cell carcinoma—Age and stage characterization and clinical implications: study of 1092 patients (1982–1997). Urology 56:58–62

5. Jayson M, Sanders H (1998) Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51:203–205

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can 18F FDG PET/CT metabolic parameters be used to noninvasively differentiate between different histopathological subtypes and Fuhrman grades of renal cell cancer?;Nuclear Medicine Communications;2024-04-30

2. The value of PET/CT for the diagnosis and evaluation of immunotherapy in occult primary renal cell carcinoma: a case report;Journal of International Medical Research;2023-04

3. Prognostic Significance of <sup>18</sup>F-FDG PET/CT Imaging in Survival Outcomes in Patients with Renal Cell Carcinoma;Molecular Imaging and Radionuclide Therapy;2022-10-19

4. Novel Imaging Methods for Renal Mass Characterization: A Collaborative Review;European Urology;2022-05

5. Glucose Metabolism Reprogramming of Primary Tumor and the Liver Is Associated With Disease-Free Survival in Patients With Early NSCLC;Frontiers in Oncology;2021-10-28